EliseAI vs Hello Patient (2026)
If your failure mode is comparing two front office agents on their containment headline without reading the security and escalation fine print, this pair rewards the closer look. Both automate patient operations across multiple channels. EliseAI reports handling 95 percent of inquiries without a human and works across voice, text, email, and chat, booking directly into the EHR, and it publishes SOC 2 Type 2. Hello Patient, founded in 2024, is the more autonomous, targeting a 100 percent answer rate across inbound and outbound, and states its HIPAA and SOC 2 Type 2 posture prominently, with slightly clearer BAA framing than EliseAI, which leaves BAA terms to the sales process. Neither publishes the escalation threshold at which a human steps in, and for triage adjacent intake that is the number to ask for.
- A higher reported containment rate, 95 percent of patient inquiries handled without human intervention, across a genuinely multi channel footprint spanning voice, text, email, and chat rather than voice first alone.
- Books, cancels, and reschedules directly in the EHR with real time updates and integrates with practice management and revenue cycle systems, with third party coverage referencing FHIR based integration.
- Support for more than 50 languages and a stated SOC 2 Type 2 and HIPAA posture, a cleaner certification claim than many peers in this category.
- Fuller autonomy across the whole front office loop, inbound and outbound: calls, booking, intake, insurance, refills, follow up, recall, and billing outreach, with practices reported eliminating unanswered calls entirely.
- Clearer security disclosure of the two: it states HIPAA and SOC 2 Type 2 prominently on its main site rather than behind a sales conversation, names its voice infrastructure partner, and its HIPAA posture is graded a step above EliseAI's.
- Candid about its stack, stating plainly that it fine tunes existing foundational and voice models rather than claiming proprietary ones, which lets a buyer reason about what sits underneath.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. EliseAI and Hello Patient are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | EliseAI | Hello Patient |
|---|---|---|
| Primary category | Patient Voice Agents | Patient Voice Agents |
| Founded | Not recorded | 2024 |
| Headquarters | New York, New York | Austin, Texas, United States |
| Website | eliseai.com | hellopatient.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards EliseAI its top capability grade on AI Centrality. Set against Hello Patient, EliseAI grades higher on Autonomy and Oversight Model. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards Hello Patient its top capability grade on AI Centrality. Set against EliseAI, Hello Patient grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose EliseAI or Hello Patient?
On the axes where the AI Health Index separates them, EliseAI grades higher on Autonomy and Oversight Model, and Hello Patient grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Hello Patient leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do EliseAI and Hello Patient differ most?
The widest separation the AI Health Index records between EliseAI and Hello Patient is on Autonomy and Oversight Model, where EliseAI grades B and Hello Patient grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do EliseAI and Hello Patient grade the same?
The AI Health Index grades EliseAI and Hello Patient the same on several axes, including AI Centrality, Clinical and Operational Evidence and Security Certifications and Trust Center. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have EliseAI and Hello Patient not disclosed?
At the last review, at least one of EliseAI and Hello Patient published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.
Both are vendor reported on operational claims with no independent validation, and both are graded thin on oversight: EliseAI describes escalation at a marketing level, and Hello Patient is graded C for its combination of high autonomy and an unpublished escalation path. On HIPAA, EliseAI sits at C because BAA availability and terms are not published, while Hello Patient sits at B, though neither publishes explicit BAA execution language.
Hello Patient was founded in 2024 with roughly a year of reported volume, so it has no longitudinal track record; EliseAI's healthcare line is graded separately from its property management business, which is out of scope here. Neither publishes pricing. Both run outbound outreach subject to TCPA consent rules, and voice accuracy can vary across accent and dialect.